OTCPK:EKTA.Y

Stock Analysis Report

Executive Summary

Elekta AB (publ) provides equipment and software for cancer and brain disorders worldwide.

Snowflake

Fundamentals

Excellent balance sheet with reasonable growth potential.


Similar Companies

Share Price & News

How has Elekta's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-1.8%

OTCPK:EKTA.Y

0.5%

US Medical Equipment

-0.02%

US Market


1 Year Return

-7.7%

OTCPK:EKTA.Y

9.9%

US Medical Equipment

1.6%

US Market

EKTA.Y underperformed the Medical Equipment industry which returned 9.7% over the past year.

EKTA.Y underperformed the Market in United States of America which returned 1.9% over the past year.


Share holder returns

EKTA.YIndustryMarket
7 Day-1.8%0.5%-0.02%
30 Day0.5%0.09%2.7%
90 Day-4.6%2.0%1.4%
1 Year-6.8%-7.7%10.8%9.9%3.8%1.6%
3 Year39.0%35.8%69.0%63.9%45.2%35.8%
5 Year39.3%34.9%136.2%109.3%61.8%44.1%

Price Volatility Vs. Market

How volatile is Elekta's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Elekta undervalued based on future cash flows and its price relative to the stock market?

41.48x

Price to Earnings (PE) ratio


Intrinsic Value Based on Future Cash Flows

Elekta's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).

Elekta's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).


Price Based on Earnings

Elekta is good value based on earnings compared to the US Medical Equipment industry average.

Elekta is overvalued based on earnings compared to the United States of America market.


Price Based on Expected Growth

Elekta is poor value based on expected growth next year.


Price Based on Value of Assets

Elekta is overvalued based on assets compared to the US Medical Equipment industry average.


Next Steps

Future Growth

How is Elekta expected to perform in the next 1 to 3 years based on estimates from 14 analysts?

19.7%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Elekta's revenue is expected to grow by 9.2% yearly, however this is not considered high growth (20% yearly).

Elekta's earnings are expected to grow by 19.7% yearly, however this is not considered high growth (20% yearly).

Elekta's revenue growth is expected to exceed the United States of America market average.

Elekta's earnings growth is expected to exceed the United States of America market average.

Elekta's earnings growth is expected to exceed the low risk savings rate of 2.7%.


Earnings per Share Growth Estimates


Future Return on Equity

Elekta is expected to efficiently use shareholders’ funds in the future (Return on Equity greater than 20%).


Next Steps

Past Performance

How has Elekta performed over the past 5 years?

15.8%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Elekta's year on year earnings growth rate has been positive over the past 5 years.

Elekta's 1-year earnings growth is negative, it can't be compared to the 5-year average.

Elekta's 1-year earnings growth is negative, it can't be compared to the US Medical Equipment industry average.


Return on Equity

Elekta has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).


Return on Assets

Elekta used its assets less efficiently than the US Medical Equipment industry average last year based on Return on Assets.


Return on Capital Employed

Elekta has improved its use of capital last year versus 3 years ago (Return on Capital Employed).


Next Steps

Financial Health

How is Elekta's financial position?


Financial Position Analysis

Elekta is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Elekta's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Elekta's level of debt (57.6%) compared to net worth is high (greater than 40%).

The level of debt compared to net worth has been reduced over the past 5 years (72.4% vs 57.6% today).

Debt is well covered by operating cash flow (30.4%, greater than 20% of total debt).

Interest payments on debt are well covered by earnings (EBIT is 16.1x coverage).


Balance Sheet

Low level of unsold assets.

Debt is covered by short term assets, assets are 2.8x debt.


Next Steps

Dividend

What is Elekta's current dividend yield, its reliability and sustainability?

1.71%

Expected Dividend Yield


Dividend Yield and Payments Analysis

Elekta's pays a lower dividend yield than the bottom 25% of dividend payers in United States of America (1.44%).

Elekta's dividend is below the markets top 25% of dividend payers in United States of America (3.69%).

Dividends per share have been volatile in the past 10 years (annual drop of over 20%).

Dividends per share have increased over the past 10 years.


Current Payout to Shareholders

Dividends paid are covered by earnings (1.7x coverage).


Future Payout to Shareholders

Dividends after 3 years are expected to be well covered by earnings (2.5x coverage).


Next Steps

Management

What is the CEO of Elekta's salary, the management and board of directors tenure and is there insider trading?

2.2yrs

Average management tenure


CEO

Richard Hausmann (59yo)

3.3yrs

Tenure

kr14,820,000

Compensation

Dr. Richard Hausmann, Ph.D. has been the Chief Executive Officer and President of Elekta AB (publ) since June 10, 2016. Dr. Hausmann has been Vice President at General Electric Company since January 1, 201 ...


CEO Compensation Analysis

Richard's remuneration is lower than average for companies of similar size in United States of America.

Richard's compensation has increased by more than 20% in the past year whilst earnings fell less than 20%.


Management Age and Tenure

2.2yrs

Average Tenure

53yo

Average Age

The tenure for the Elekta management team is about average.


Board Age and Tenure

6.3yrs

Average Tenure

62yo

Average Age

The tenure for the Elekta board of directors is about average.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Laurent Leksell (67yo)

    Founder & Chairman

    • Tenure: 6yrs
    • Compensation: kr1.28m
  • Richard Hausmann (59yo)

    President & CEO

    • Tenure: 3.3yrs
    • Compensation: kr14.82m
  • Karin Nyberg (53yo)

    Executive Vice President of Human Resources

    • Tenure: 2.7yrs
  • Oskar Bosson (43yo)

    Executive Vice President of Corporate Communications & Public Affairs

    • Tenure: 1.6yrs
  • Caroline Mofors (47yo)

    Senior VP

    • Tenure: 5yrs
  • Jonas Bolander (53yo)

    General Counsel

    • Tenure: 2.8yrs
  • Gustaf Salford (42yo)

    CFO & Executive VP

    • Tenure: 2.2yrs
  • Ioannis Panagiotelis (47yo)

    Chief Marketing & Sales Officer

    • Tenure: 2.1yrs
  • Steve Wort (56yo)

    Chief Operating Officer

    • Tenure: 2yrs
  • Cecilia Ketels

    Head of Investor Relations

    • Tenure: 0.3yrs

Board Members

  • Jan Secher (62yo)

    Independent Director

    • Tenure: 9.7yrs
    • Compensation: kr635.00k
  • Wolfgang Reim (63yo)

    Independent Director

    • Tenure: 8.7yrs
    • Compensation: kr575.00k
  • Tomas Puusepp (64yo)

    Non-Executive Director

    • Tenure: 6.7yrs
    • Compensation: kr500.00k
  • Laurent Leksell (67yo)

    Founder & Chairman

    • Tenure: 6yrs
    • Compensation: kr1.28m
  • Johan Malmquist (58yo)

    Independent Director

    • Tenure: 4.7yrs
    • Compensation: kr635.00k
  • Birgitta Göransson (62yo)

    Independent Director

    • Tenure: 14.7yrs
    • Compensation: kr725.00k
  • Caroline Cooke (38yo)

    Director

    • Tenure: 2.1yrs
    • Compensation: kr635.00k
  • Cecilia Wikström (54yo)

    Independent Director

    • Tenure: 1.1yrs
    • Compensation: kr575.00k

Company Information

Elekta AB (publ)'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Elekta AB (publ)
  • Ticker: EKTA.Y
  • Exchange: OTCPK
  • Founded: 1972
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: kr48.899b
  • Listing Market Cap: kr5.045b
  • Shares outstanding: 382.03m
  • Website: https://www.elekta.com

Number of Employees


Location

  • Elekta AB (publ)
  • Box 7593
  • Kungstensgatan 18
  • Stockholm
  • Stockholm County
  • 103 93
  • Sweden

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
EKTA.FOTCPK (Pink Sheets LLC)YesSeries B Registered SharesUSUSDMar 1994
EKTA BOM (OMX Nordic Exchange Stockholm)YesSeries B Registered SharesSESEKMar 1994
EJXBDB (Deutsche Boerse AG)YesSeries B Registered SharesDEEURMar 1994
0O5HLSE (London Stock Exchange)YesSeries B Registered SharesGBSEKMar 1994
EKTABSBATS-CHIXE (BATS 'Chi-X Europe')YesSeries B Registered SharesGBSEKMar 1994
EKTA.YOTCPK (Pink Sheets LLC)UNSPONSOD ADRUSUSDDec 2008

Biography

Elekta AB (publ) provides equipment and software for cancer and brain disorders worldwide. The company offers radiotherapy systems under the Versa HD, Precise Treatment System, and Elekta Compact names; El ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/19 00:04
End of Day Share Price2019/09/18 00:00
Earnings2019/07/31
Annual Earnings2019/04/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.